This course focuses on the management and treatment of Demodex blepharitis (DB), including at-home and in-office options. In-depth discussion focuses on the SATURN-1 and SATURN-2 clinical studies, which investigated the treatment of DB with lotilaner.

To watch the full-length video, enter your information on the right.

To claim credit, log into the TFG Learning Center and take this course.

This activity, COPE Activity Number 128066, is accredited by COPE for continuing education for optometrists.
COPE Course No.: 90119-TD

Release Date: 03-29-2024
Expiration Date: 03-28-2025

Grant Support Statement
This activity is supported by unrestricted educational grants from Alcon, Horizon Therapeutics, SightSciences, and Tarsus Pharmaceuticals, Inc.